Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 2, 2024Cancer Research

Abstract PO4-16-01: EZH2 is Overexpressed in Invasive Carcinoma and DCIS in both BRCA1 and BRCA2 Mutation Carriers

View Full Paper
Ask AI
Bookmark
Share

Authors

TDTábata Alves DomingosRPRoberto Bonfim Pimenta PeixotoRARodrigo Fonseca Abreu

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Domingos et al. (2024) studied this question.

synapsesocial.com/papers/68e6be8ab6db64358763e288https://doi.org/10.1158/1538-7445.sabcs23-po4-16-01
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Abstract PO2-15-01: EZH2 protein expression in early hormone receptor positive HER2 negative breast cancer with high recurrence score2024
  2. 2EZH2 Expression and Clinical Outcomes in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: A Real-World Retrospective Cohort Study2026
  3. 3Abstract PO3-15-10: Enhanced Cancer Cell Proliferation and Aggressive Phenotype Counterbalance in Breast Cancer with High BRCA1 Gene Expression2024
  4. 4EZH2 Expression Is Associated With Sensitivity to Inhibitors and Promotes Malignancy in Endometrial Cancer Cells2026
  5. 5Abstract 2524: Molecular and clinicopathologic landscape of HER2 positive breast cancer: A single institution study2024